| Literature DB >> 23852812 |
Anne J Jääskeläinen1, Pekka Kolehmainen, Liina Voutilainen, Heidi C Hauffe, Hannimari Kallio-Kokko, Maija Lappalainen, Conny Tolf, A Michael Lindberg, Heikki Henttonen, Antti Vaheri, Sisko Tauriainen, Olli Vapalahti.
Abstract
Ljungan virus (LV, genus Parechovirus, family Picornaviridae) is considered currently to be a rodent-borne virus. Despite suggested human disease associations, its zoonotic potential remains unclear. To date, LV antibody prevalence in both humans and rodents has not been studied. In this study, two different LV immunofluorescence assays (LV IFAs) were developed with LV genotypes 1 (LV strain 87-012G) and 2 (LV strain 145SLG), and cross-neutralization and -reaction studies were carried out with LV strain 145SLG. Finally, a panel of 37 Finnish sera was screened for anti-LV antibodies using two different LV IFAs (LV 145SLG and LV 87-012G) and a neutralization (NT) assay (LV 145SLG), and 50 samples from Myodes glareolus by LV IFA (LV 145SLG). The LV seroprevalence study showed 38% and 18% positivity in humans and M. glareolus, respectively. LV IFAs and NT assays were compared, and the results were in good agreement. The data are the first evidence of humans and rodents coming into contact with LV in Finland. Additional studies are required in order to acquire a better understanding of the prevalence, epidemiological patterns and possible disease association of LV infections.Entities:
Keywords: Ljungan virus; human parechovirus; immunofluorescence assay; neutralization; seroprevalence
Mesh:
Substances:
Year: 2013 PMID: 23852812 DOI: 10.1002/jmv.23681
Source DB: PubMed Journal: J Med Virol ISSN: 0146-6615 Impact factor: 2.327